Medicines under evaluation

2021
2020
2019
2018
2017
2016
2015
2014
2013
2012

This page lists information on applications for centralised marketing authorisations for human medicines that are under evaluation by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).

The list of medicines under evaluation is updated each month. It includes the international non-proprietary names (INN) and therapeutic areas for all new innovative medicines under evaluation by the CHMP. For generic and biosimilar medicines, it includes the INN (active moiety only, with no information on salt, ester or derivative) and therapeutic area.

Medicines under evaluation

Table of contents

2021

Applications for new human medicines under evaluation by the CHMP: January 2021 (PDF/104.11 KB) (new)

2020

Applications for new human medicines under evaluation by the CHMP: December 2020 (PDF/104.72 KB)

Applications for new human medicines under evaluation by the CHMP: November 2020 (PDF/101.55 KB)

Applications for new human medicines under evaluation by the CHMP: October 2020 (PDF/102.14 KB)

Applications for new human medicines under evaluation by the CHMP: September 2020 (PDF/101.73 KB)

Applications for new human medicines under evaluation by the CHMP: August 2020 (PDF/101.16 KB)

Applications for new human medicines under evaluation by the CHMP: July 2020 (PDF/101.29 KB)

Applications for new human medicines under evaluation by the CHMP: June 2020 (PDF/101.77 KB)

Applications for new human medicines under evaluation by the CHMP: May 2020 (PDF/101.46 KB)

Applications for new human medicines under evaluation by the CHMP: April 2020 (PDF/103.18 KB)

Applications for new human medicines under evaluation by the CHMP: March 2020 (PDF/101.65 KB)

Applications for new human medicines under evaluation by the CHMP: February 2020 (PDF/100.99 KB)

Applications for new human medicines under evaluation by the CHMP: January 2020 (PDF/101.17 KB)

2019

Applications for new human medicines under evaluation by the CHMP: January 2019 (PDF/98.2 KB)

Applications for new human medicines under evaluation by the CHMP: December 2019 (PDF/103.36 KB)

Applications for new human medicines under evaluation by the CHMP: November 2019 (PDF/102.41 KB)

Applications for new human medicines under evaluation by the CHMP: October 2019 (PDF/102.39 KB)

Applications for new human medicines under evaluation by the CHMP: September 2019 (PDF/102.55 KB)

Applications for new human medicines under evaluation by the CHMP: August 2019 (PDF/101.06 KB)

Applications for new human medicines under evaluation by the CHMP: July 2019 (PDF/100.74 KB)

Applications for new human medicines under evaluation by the CHMP: June 2019 (PDF/100.62 KB)

Applications for new human medicines under evaluation by the CHMP: May 2019 (PDF/100.2 KB)

Applications for new human medicines under evaluation by the CHMP: April 2019 (PDF/101.13 KB)

Applications for new human medicines under evaluation by the CHMP: March 2019 (PDF/100.42 KB)

Applications for new human medicines under evaluation by the CHMP: February 2019 (PDF/100.22 KB)

2018

Applications for new human medicines under evaluation by the CHMP: December 2018 (PDF/99.85 KB)

Applications for new human medicines under evaluation by the CHMP: November 2018 (PDF/100.25 KB)

Applications for new human medicines under evaluation by the CHMP: October 2018 (PDF/98.25 KB)

Applications for new human medicines under evaluation by the CHMP: September 2018 (PDF/99.74 KB)

Applications for new human medicines under evaluation by the CHMP: August 2018 (PDF/97.9 KB)

Applications for new human medicines under evaluation by the CHMP: July 2018 (PDF/119.81 KB)

Applications for new human medicines under evaluation by the CHMP: June 2018 (PDF/100.48 KB)

Applications for new human medicines under evaluation by the CHMP: May 2018 (PDF/99.65 KB)

Applications for new human medicines under evaluation by the CHMP: April 2018 (PDF/99.9 KB)

Applications for new human medicines under evaluation by the CHMP: March 2018 (PDF/99.73 KB)

Applications for new human medicines under evaluation by the CHMP: February 2018 (PDF/104.72 KB)

Applications for new human medicines under evaluation by the CHMP: January 2018 (PDF/100.28 KB)

2017

Applications for new human medicines under evaluation by the CHMP: December 2017 (PDF/103.81 KB)

Applications for new human medicines under evaluation by the CHMP: November 2017 (PDF/105.03 KB)

Applications for new human medicines under evaluation by the CHMP: October 2017 (PDF/100.38 KB)

Applications for new human medicines under evaluation by the CHMP: September 2017 (PDF/130.13 KB)

Applications for new human medicines under evaluation by the CHMP: August 2017 (PDF/117.37 KB)

Applications for new human medicines under evaluation by the CHMP: July 2017 (PDF/128.5 KB)

Applications for new human medicines under evaluation by the CHMP: June 2017 (PDF/133.25 KB)

Applications for new human medicines under evaluation by the CHMP: May 2017 (PDF/129.73 KB)

Applications for new human medicines under evaluation by the CHMP: April 2017 (PDF/136.83 KB)

Applications for new human medicines under evaluation by the CHMP: March 2017 (PDF/137.73 KB)

Applications for new human medicines under evaluation by the CHMP: February 2017 (PDF/133.36 KB)

Applications for new human medicines under evaluation by the CHMP: January 2017 (PDF/135.63 KB)

2016

Applications for new human medicines under evaluation by the CHMP: January 2016 (PDF/173.56 KB)

Applications for new human medicines under evaluation by the CHMP: December 2016 (PDF/135.48 KB)

Applications for new human medicines under evaluation by the CHMP: November 2016 (PDF/166.29 KB)

Applications for new human medicines under evaluation by the CHMP: October 2016 (PDF/136.11 KB)

Applications for new human medicines under evaluation by the CHMP: September 2016 (PDF/129.91 KB)

Applications for new human medicines under evaluation by the CHMP: August 2016 (PDF/132.82 KB)

Applications for new human medicines under evaluation by the CHMP: July 2016 (PDF/132.49 KB)

Applications for new human medicines under evaluation by the CHMP: June 2016 (PDF/130.18 KB)

Applications for new human medicines under evaluation by the CHMP: May 2016 (PDF/131.98 KB)

Applications for new human medicines under evaluation by the CHMP: April 2016 (PDF/136.22 KB)

Applications for new human medicines under evaluation by the CHMP: March 2016 (PDF/135.07 KB)

Applications for new human medicines under evaluation by the CHMP: February 2016 (PDF/129.59 KB)

2015

Applications for new human medicines under evaluation by the CHMP: December 2015 (PDF/134.67 KB)

Applications for new human medicines under evaluation by the CHMP: November 2015 (PDF/134.87 KB)

Applications for new human medicines under evaluation by the CHMP: October 2015 (PDF/128.59 KB)

Applications for new human medicines under evaluation by the CHMP: September 2015 (PDF/136.4 KB)

Applications for new human medicines under evaluation by the CHMP: August 2015 (PDF/130.71 KB)

Applications for new human medicines under evaluation by the CHMP: July 2015 (PDF/130.98 KB)

Applications for new human medicines under evaluation by the CHMP: June 2015 (PDF/139.44 KB)

Applications for new human medicines under evaluation by the CHMP: May 2015 (PDF/130.23 KB)

Applications for new human medicines under evaluation by the CHMP: April 2015 (PDF/129.8 KB)

Applications for new human medicines under evaluation by the CHMP: March 2015 (PDF/138.29 KB)